May, 2026
CTCs & Xenografts white paper: The Parsortix Platform as a tool to support innovative xenograft-based discovery projects.
CTCs & Xenografts white paper
February, 2025
From blood to breakthroughs: how multi-analyte liquid biopsies can transform precision oncology, drug development and clinical trials
Published by International Clinical Trials, © Samedan Ltd.
May, 2023
Liquid Biopsy in Cancer Care – Improving Patient Outcomes and Reducing Healthcare Costs
Published by International Clinical Trials, © Samedan Ltd.
August, 2022
ANGLE achieves world first with FDA clearance for its Parsortix PC1 clinical system
Published by SHARES spotlight
May, 2021
ANGLE plc -Transforming cancer care with a liquid biopsy from a simple blood test
Published by SHARES spotlight
January, 2021
The impact of COVID-19 on cancer diagnosis and care
Andrew Newland, CEO ANGLE plc, published by European Biopharmaceutical Review